List of works - Zheng-Xiong Xi

(±)VK4-40, a Novel D3 R Partial Agonist, Attenuates Cocaine Reward and Relapse in Rodents

scientific article published on 27 August 2020

Beta-caryophyllene inhibits cocaine self-administration by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

scientific article published on 17 October 2020

CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

scientific article published on 18 August 2016

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms

scientific article published on 19 August 2019

Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents

scientific article published on 19 June 2019

Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

scientific article

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

article published in the Proceedings of the National Academy of Sciences of the United States of America

Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats

scientific article published on 03 October 2018

Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1 /CB2 versus GPR55 receptors

scientific article published on 11 February 2020

Dissecting the role of GABA neurons in the VTA versus SNr in opioid reward

scientific article published on 12 October 2020

Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice

scientific article published on 15 November 2018

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals

scientific article published on 24 December 2020

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

scientific article published on 01 October 2019

Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope

scientific article

T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice

scientific article published on October 2016

The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic

scientific article

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

scientific article published on 11 March 2019

Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence

scientific article published on 28 October 2019

β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

scientific article published on 27 December 2019

List of works by Zheng-Xiong Xi

(±)VK4-40, a Novel D3 R Partial Agonist, Attenuates Cocaine Reward and Relapse in Rodents

Beta-caryophyllene inhibits cocaine self-administration by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms

Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents

Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats

Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1 /CB2 versus GPR55 receptors

Dissecting the role of GABA neurons in the VTA versus SNr in opioid reward

Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope

T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice

The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence

β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents